Genterpret's Seed Round

Genterpret raised a round of funding on July 13, 2013. Investors include Blueprint Health.

Genterpret helps pharmaceutical companies quickly and cost effectively gain access to genetic and clinical datasets linking genetics to drug response. We quickly enroll patients through direct outreac…

Articles about Genterpret's Seed Round: